search
Back to results

Preventing the Risk of Osteoporotic Fracture in Premenopausal Women by a Spa Residential Physical Activity Program (ThermOs)

Primary Purpose

Osteoporotic Fracture

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
9 days spa residential program
3 sessions of 10 minutes per day of physical exercise
Sponsored by
University Hospital, Clermont-Ferrand
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Osteoporotic Fracture focused on measuring prevention, bone, physical activity, spa bath, women

Eligibility Criteria

40 Years - 50 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Women with regular cycles
  • 40-50 years old
  • Sedentary lifestyle
  • stable body weight over the previous 6 months
  • Normal weighted (BMI<30)
  • written informed consent.
  • Affiliated to French health care system (for France)

Exclusion Criteria:

  • Menopausal women
  • Regular physical activity > 4 hours / week of moderate or high intensities
  • Participant refusal to participate
  • Hepatic, renal, or psychiatric diseases, nor cardiovascular or endocrine diseases (thyroid diseases will be included)
  • HIV infection
  • Use of medications altering body weight, corticosteroids, Nonsteroidal anti-inflammatory drugs
  • Use of medications influencing bone parameters such as bisphosphonate, other osteoporotic treatment therapy, or chemotherapy
  • Regular alcohol consumption (>20g of alcohol per day)
  • Restricted diet over the previous 6 months
  • Deficit or supplementation in vitamin D
  • Protected persons are not excluded

Sites / Locations

  • CHU Clermont-FerrandRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Active Comparator

Arm Label

Sp-Ex

Sp-alone

Ex-alone

Arm Description

a 9 days spa residential program including physical activity. 3 sessions of 10 minutes per day of physical exercise for bone health improvements supervised by a professional of adapted physical activity. Participants will benefit advices from national plan for physical activity and nutrition (NPPN)

Participants will benefit a short term spa residential program of 9 days. In addition they will benefit advices from national plan for physical activity and nutrition (NPPN)

Participants will benefit 3 sessions of 10 minutes per day of physical exercise for bone health improvements supervised by a professional of adapted physical activity. Participants will benefit advices from national plan for physical activity and nutrition (NPPN)

Outcomes

Primary Outcome Measures

Variation of bone cortical porosity in premenopausal women after the interventional phase.
To evaluate the effectiveness of a spa residential program including physical activity (Sp-Ex) on bone cortical porosity compared with a spa residential program alone (Sp-alone) or physical activity alone (Ex-alone), in premenopausal women.
Variation of bone cortical porosity in premenopausal women
To evaluate the effectiveness of a spa residential program including physical activity (Sp-Ex) on bone cortical porosity compared with a spa residential program alone (Sp-alone) or physical activity alone (Ex-alone), in premenopausal women.
Variation of bone cortical porosity in premenopausal women
To evaluate the effectiveness of a spa residential program including physical activity (Sp-Ex) on bone cortical porosity compared with a spa residential program alone (Sp-alone) or physical activity alone (Ex-alone), in premenopausal women.
Variation of bone cortical porosity in premenopausal women
To evaluate the effectiveness of a spa residential program including physical activity (Sp-Ex) on bone cortical porosity compared with a spa residential program alone (Sp-alone) or physical activity alone (Ex-alone), in premenopausal women.

Secondary Outcome Measures

bone fracture risk
questionnaire (FRAX - Fracture Risk Assessment Tool, bone fracture risks ; after registering results from DXA and personal details the computer calculates the fracture risks based on an algorithm)
General Health
General Health will be measured using the General Health Questionnaire, (there is no score, just informative health information)
Greater short-term benefits on health factors with the Sp-Ex program than with Sp-alone or Ex-alone (Bone health will be obtained from the combination of 5 measures).
Evaluate the effectiveness of the Sp-Ex program compared with the Sp-alone or Ex-alone on short-term modification of health factors among premenopausal women.
Physical Activity
Quality of life will be measured using the SF-36 (Short Form 36 ; 9 sections questionnaire ; scale range from 0 (bad) to 100(excellent))
Quality of life
Calcium intake will be measured using the Fardellonne questionnaire (recommended daily consummation in France: women 900 mg/d; women >55 years old 1200mg/d)
Calcium intake
Depression and anxiety will be measured using Hamilton scale (scale range from 0 to 4, if > 20 high level of anxiety)
Depression and anxiety
Depression and anxiety will be measured using the Hospital anxiety and depression scale (scale range from 0 to 3, with a total score between 0 to 21. Threshold score is 8)
Depression and anxiety
anxiety will be measured using the state and trait anxiety inventory scale (scale range from 1 to 4, with a total score between 20 to 80. If <35 poor level of anxiety, if > 66 very high level of anxiety)
Anxiety
Burn-out will be measured using the Maslach Burn Out Inventory (scale range from 0 to 6, with 0 = never and 6 = almost always)
Burn-out
Job content will be measured using the Karasek questionnaire (scale range from 1 to 4, with 1= not agreed and 4 = totally agreed)
Job content
Job content will be measured using the Karasek questionnaire (scale range from 1 to 4, with 1= not agreed and 4 = totally agreed)
Body mass
Body mass (muscle and fat) will be measured using Impedancemeter
Anthropometry
weight (kg) will be obtained according to the ISAK (International Society for the Advancement of Kinanthropometry) recommendations
Anthropometry
height (m) will be obtained according to the ISAK (International Society for the Advancement of Kinanthropometry) recommendations
Anthropometry
waist circumference (cm) will be obtained according to the ISAK (International Society for the Advancement of Kinanthropometry) recommendations
Basic biology
HbA1c (mmol/mol) will be measured using endocrine assays
Basic biology
HDLc (mmol/L) will be measured using endocrine assays
Basic biology
LDL-cholesterol (mmol/L) will be measured using endocrine assays
Basic biology
Triglyceride (TG-mmol/L) will be measured using endocrine assays
Vitamin D
Vitamin D will be measured using endocrine assays
Leptin
Leptin will be measured using endocrine assays
Pro-inflammatory cytokine
Pro-inflammatory cytokine (IL-1β, IL-6, IL-1, TNFα, IFNγ) will be measured using endocrine assays
heart rate variability
heart rate variability will be measured using Holter
electrodermal activity
electrodermal activity (skin conductance) will be measured using Wirst band electrodes
physical activity behaviour
physical activity behaviour will be measured using an activity journal (participant will have to write all their daily activity from when they wake up to when they go to bed)
physical activity behaviour
will be measured using an accelerometer-pedometer watch (daily step count)

Full Information

First Posted
March 26, 2018
Last Updated
June 15, 2018
Sponsor
University Hospital, Clermont-Ferrand
Collaborators
Regional Council of Auvergne-Rhône-Alpes, European Regional Development Fund, Spa resort of Chaudes Aigues, 27 avenue Georges Pompidou, BP21, 15110 Chaudes Aigues, France, Spa resort of Bourbon-Lancy, place d'Aligre 71140 Bourbon-Lancy, France, Innovatherm, Université d'Auvergne
search

1. Study Identification

Unique Protocol Identification Number
NCT03570008
Brief Title
Preventing the Risk of Osteoporotic Fracture in Premenopausal Women by a Spa Residential Physical Activity Program
Acronym
ThermOs
Official Title
Preventing the Risk of Osteoporotic Fracture in Premenopausal Women by a Spa Residential Physical Activity Program
Study Type
Interventional

2. Study Status

Record Verification Date
June 2018
Overall Recruitment Status
Unknown status
Study Start Date
March 1, 2017 (Actual)
Primary Completion Date
March 1, 2021 (Anticipated)
Study Completion Date
March 1, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Clermont-Ferrand
Collaborators
Regional Council of Auvergne-Rhône-Alpes, European Regional Development Fund, Spa resort of Chaudes Aigues, 27 avenue Georges Pompidou, BP21, 15110 Chaudes Aigues, France, Spa resort of Bourbon-Lancy, place d'Aligre 71140 Bourbon-Lancy, France, Innovatherm, Université d'Auvergne

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Osteoporosis is an increasing public health problem. Involution of bone mass in women is due to a reduction in sensitivity of the bone to the mechanical stress due to the slow-down of the bone turnover after 35 years old. Osteoporosis is a silent disease combining a decrease in bone mass (quantity) and an impaired bone microarchitecture (quality) leading to an increased risk of fracture. Bone microarchitecture is an important element to be taken into account in assessing the bone properties, as demonstrated by numerous ex vivo studies. Bone densitometry only identifies 50% of osteoporotic fractures. The other half of the fractures appears in osteopenic women. The measurement of bone mineral density is too limited to assess risk of fracture. Bone microarchitecture can be assessed through a peripheral quantitative computed tomography scan (computed tomography peripherical - pQCT). The microarchitecture data allow the calculation of bone strength index (BSI) and stress strength index (SSI) highly predictive of fracture risk. These qualitative determinants of bone fragility are the most relevant to evaluate effect of physical activity over a short period compared with bone mineral content and density, which requires several months of constraints. Biochemical markers of bone turnover, specifically those of bone resorption, are predictive of the risk of osteoporotic fracture. Physical activity can reduce the risk of fracture up to 20-35% via direct effects on bone strength, at any age. However, response of bone varies with modalities of exercise. Repeated exercise produces greater bone adaptations than a single bout. Moreover, it has been well demonstrated since 1970 that bone responds to a dynamic stimulation, but not a static stimulation, with a dose response relationship. It has been confirmed in premenopausal women. The effect of physical activity on microarchitectural bone parameters (porosity and density of cortical and trabecular) has not been investigated in primary prevention. This original study would highlight the effect of short-term specific physical activity on the prevention of bone fragility (qualitative) observed with age in premenopausal women. The main hypothesis is that a spa residential program including physical activity will have greater benefits on bone cortical porosity than a spa residential program alone or physical activity alone, in premenopausal women.
Detailed Description
The ThermOs protocol was designed to provide a better understanding of the effect of physical activity on microarchitectural bone parameters (porosity and density of cortical and trabecular), in prevention of bone fragility among premenopausal women. In the present protocol, parameters are measured on four occasions (baseline, 10 days, at 6 months and at 12 months). Statistical analysis will be performed using Stata software (version 13; Stata-Corp, College Station, Tex., USA). All statistical tests will be two-sided and p<0.05 will be considered significant. After testing for normal distribution (Shapiro-Wilk test), data will be treated either by parametric or non-parametric analyses according to statistical assumptions. Inter-groups comparisons will systematically be performed 1) without adjustment and 2) adjusting on factors liable to be biased between groups. Analysis will be performed using anova or Kruskal-Wallis (KW) tests. When appropriate (p<0.05), a post-hoc test for multiple comparisons (Tukey-Kramer after anova and Dunn post KW) will be used. Linear regression (with logarithmic transformation if necessary) considering an adjustment on covariates fixed according to epidemiological relevance and observance to physical activity will complete the analysis. Relations between quantitative outcomes will be analyzed using correlation coefficients (Pearson or Spearman) and compared with Chi-squared or Fischer test. Longitudinal data will be treated using mixt-model analyses in order to treat fixed effects group, time and group x time interaction taking into account between and within participant variability.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoporotic Fracture
Keywords
prevention, bone, physical activity, spa bath, women

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Masking Description
No masking
Allocation
Randomized
Enrollment
90 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Sp-Ex
Arm Type
Experimental
Arm Description
a 9 days spa residential program including physical activity. 3 sessions of 10 minutes per day of physical exercise for bone health improvements supervised by a professional of adapted physical activity. Participants will benefit advices from national plan for physical activity and nutrition (NPPN)
Arm Title
Sp-alone
Arm Type
Active Comparator
Arm Description
Participants will benefit a short term spa residential program of 9 days. In addition they will benefit advices from national plan for physical activity and nutrition (NPPN)
Arm Title
Ex-alone
Arm Type
Active Comparator
Arm Description
Participants will benefit 3 sessions of 10 minutes per day of physical exercise for bone health improvements supervised by a professional of adapted physical activity. Participants will benefit advices from national plan for physical activity and nutrition (NPPN)
Intervention Type
Behavioral
Intervention Name(s)
9 days spa residential program
Intervention Description
After the inclusion visit, the participants will be involved in a short-term spa residential program of 9 days (Sp). The will be randomized into 3 groups of 30 participants: Sp-Ex: spa residential program including physical activity Sp-alone: spa residential program alone Ex-alone: physical activity alone After the spa residential program, participants will undergo a one-year at-home follow-up. The participants will be required to complete the same program by themselves. A journal and an accelerometer-pedometer watch will record the weekly physical activity performed. Monitoring will be further monthly assessed by a health-care professional from the spa resorts.
Intervention Type
Behavioral
Intervention Name(s)
3 sessions of 10 minutes per day of physical exercise
Intervention Description
After the inclusion visit, the participants will be involved in a short-term spa residential program of 9 days (Sp). The will be randomized into 3 groups of 30 participants: Sp-Ex: spa residential program including physical activity Sp-alone: spa residential program alone Ex-alone: physical activity alone After the spa residential program, participants will undergo a one-year at-home follow-up. The participants will be required to complete the same program by themselves. A journal and an accelerometer-pedometer watch will record the weekly physical activity performed. Monitoring will be further monthly assessed by a health-care professional from the spa resorts.
Primary Outcome Measure Information:
Title
Variation of bone cortical porosity in premenopausal women after the interventional phase.
Description
To evaluate the effectiveness of a spa residential program including physical activity (Sp-Ex) on bone cortical porosity compared with a spa residential program alone (Sp-alone) or physical activity alone (Ex-alone), in premenopausal women.
Time Frame
at Baseline
Title
Variation of bone cortical porosity in premenopausal women
Description
To evaluate the effectiveness of a spa residential program including physical activity (Sp-Ex) on bone cortical porosity compared with a spa residential program alone (Sp-alone) or physical activity alone (Ex-alone), in premenopausal women.
Time Frame
after 10 days
Title
Variation of bone cortical porosity in premenopausal women
Description
To evaluate the effectiveness of a spa residential program including physical activity (Sp-Ex) on bone cortical porosity compared with a spa residential program alone (Sp-alone) or physical activity alone (Ex-alone), in premenopausal women.
Time Frame
after 6 months
Title
Variation of bone cortical porosity in premenopausal women
Description
To evaluate the effectiveness of a spa residential program including physical activity (Sp-Ex) on bone cortical porosity compared with a spa residential program alone (Sp-alone) or physical activity alone (Ex-alone), in premenopausal women.
Time Frame
after 12 months
Secondary Outcome Measure Information:
Title
bone fracture risk
Description
questionnaire (FRAX - Fracture Risk Assessment Tool, bone fracture risks ; after registering results from DXA and personal details the computer calculates the fracture risks based on an algorithm)
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
General Health
Description
General Health will be measured using the General Health Questionnaire, (there is no score, just informative health information)
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Greater short-term benefits on health factors with the Sp-Ex program than with Sp-alone or Ex-alone (Bone health will be obtained from the combination of 5 measures).
Description
Evaluate the effectiveness of the Sp-Ex program compared with the Sp-alone or Ex-alone on short-term modification of health factors among premenopausal women.
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Physical Activity
Description
Quality of life will be measured using the SF-36 (Short Form 36 ; 9 sections questionnaire ; scale range from 0 (bad) to 100(excellent))
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Quality of life
Description
Calcium intake will be measured using the Fardellonne questionnaire (recommended daily consummation in France: women 900 mg/d; women >55 years old 1200mg/d)
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Calcium intake
Description
Depression and anxiety will be measured using Hamilton scale (scale range from 0 to 4, if > 20 high level of anxiety)
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Depression and anxiety
Description
Depression and anxiety will be measured using the Hospital anxiety and depression scale (scale range from 0 to 3, with a total score between 0 to 21. Threshold score is 8)
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Depression and anxiety
Description
anxiety will be measured using the state and trait anxiety inventory scale (scale range from 1 to 4, with a total score between 20 to 80. If <35 poor level of anxiety, if > 66 very high level of anxiety)
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Anxiety
Description
Burn-out will be measured using the Maslach Burn Out Inventory (scale range from 0 to 6, with 0 = never and 6 = almost always)
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Burn-out
Description
Job content will be measured using the Karasek questionnaire (scale range from 1 to 4, with 1= not agreed and 4 = totally agreed)
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Job content
Description
Job content will be measured using the Karasek questionnaire (scale range from 1 to 4, with 1= not agreed and 4 = totally agreed)
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Body mass
Description
Body mass (muscle and fat) will be measured using Impedancemeter
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Anthropometry
Description
weight (kg) will be obtained according to the ISAK (International Society for the Advancement of Kinanthropometry) recommendations
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Anthropometry
Description
height (m) will be obtained according to the ISAK (International Society for the Advancement of Kinanthropometry) recommendations
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Anthropometry
Description
waist circumference (cm) will be obtained according to the ISAK (International Society for the Advancement of Kinanthropometry) recommendations
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Basic biology
Description
HbA1c (mmol/mol) will be measured using endocrine assays
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Basic biology
Description
HDLc (mmol/L) will be measured using endocrine assays
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Basic biology
Description
LDL-cholesterol (mmol/L) will be measured using endocrine assays
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Basic biology
Description
Triglyceride (TG-mmol/L) will be measured using endocrine assays
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Vitamin D
Description
Vitamin D will be measured using endocrine assays
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Leptin
Description
Leptin will be measured using endocrine assays
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
Pro-inflammatory cytokine
Description
Pro-inflammatory cytokine (IL-1β, IL-6, IL-1, TNFα, IFNγ) will be measured using endocrine assays
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
heart rate variability
Description
heart rate variability will be measured using Holter
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
electrodermal activity
Description
electrodermal activity (skin conductance) will be measured using Wirst band electrodes
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
physical activity behaviour
Description
physical activity behaviour will be measured using an activity journal (participant will have to write all their daily activity from when they wake up to when they go to bed)
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months
Title
physical activity behaviour
Description
will be measured using an accelerometer-pedometer watch (daily step count)
Time Frame
at Baseline, after 10 days, after 6 months, after 12 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Women with regular cycles 40-50 years old Sedentary lifestyle stable body weight over the previous 6 months Normal weighted (BMI<30) written informed consent. Affiliated to French health care system (for France) Exclusion Criteria: Menopausal women Regular physical activity > 4 hours / week of moderate or high intensities Participant refusal to participate Hepatic, renal, or psychiatric diseases, nor cardiovascular or endocrine diseases (thyroid diseases will be included) HIV infection Use of medications altering body weight, corticosteroids, Nonsteroidal anti-inflammatory drugs Use of medications influencing bone parameters such as bisphosphonate, other osteoporotic treatment therapy, or chemotherapy Regular alcohol consumption (>20g of alcohol per day) Restricted diet over the previous 6 months Deficit or supplementation in vitamin D Protected persons are not excluded
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Patrick LACARIN
Phone
0473751195
Email
placarin@chu-clermontferrand.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Frederic DUTHEIL
Organizational Affiliation
University Hospital, Clermont-Ferrand
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Clermont-Ferrand
City
Clermont-Ferrand
ZIP/Postal Code
63003
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Patrick LACARIN
Phone
0473751195
Email
placarin@chu-clermontferrand.fr
First Name & Middle Initial & Last Name & Degree
Frederic DUTHEIL

12. IPD Sharing Statement

Learn more about this trial

Preventing the Risk of Osteoporotic Fracture in Premenopausal Women by a Spa Residential Physical Activity Program

We'll reach out to this number within 24 hrs